Cutler Group LP Alaunos Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$1.04 - $322.5 $9,256 - $2.87 Million	8,900 New	8,900 $7,000
Q1 2022 Apr 14, 2022	SELL	$0.62 - $1.17 $1,550 - $2,925	-2,500 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$2.63 - $3.67 $6,575 - $9,175	2,500 New	2,500 $2,000
Q1 2019 May 10, 2019	SELL	$2.0 - $4.4 $400 - $880	-200 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$1.61 - $3.62 $322 - $724	-200 Reduced 50.0%	200 $0
Q3 2018 Nov 07, 2018	BUY	$2.26 - $3.27 $451 - $654	200 Added 100.0%	400 $0
Q1 2018 May 11, 2018	SELL	$3.46 - $5.14 $6,920 - $10,280	-2,000 Reduced 90.91%	200 $0
Q4 2017 Jan 17, 2018	SELL	$4.0 - $6.54 $18,800 - $30,738	-4,700 Reduced 68.12%	2,200 $0
Q3 2017 Oct 17, 2017	BUY	$4.99 - $6.57 $34,431 - $45,333	6,900	6,900 $41,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.